Oscar Health Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 2.5× Oscar Health Inc's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| OSCR | RPRX | |
|---|---|---|
Market Cap | $10.22B | $25.27B |
Volume | 4,123,394 | 3,671,183 |
Sector | Health | Health |
52-Week High | $33.81 | $63.96 |
52-Week Low | $10.85 | $35.44 |
Typical Hold Time | 15 Days | 1 Days |
Enterprise Value | $6.57B | $32.50B |
Dividend Yield | — | 1.66% |
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →